ni.zielinski
Submits third-party assay reports on material purchased directly. Based in Kumasi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.09%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041957 | Sermorelin | AMB | AMB-2512-V5420 | VendorInvestigate | 2026-Q2 | 99.11 | 4.02 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041669 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y8741 | Janoshik | 2026-Q2 | 99.39 | 4.82 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042830 | Retatrutide | GGPeps | GGPE-2511-W2357 | PeptideMeter | 2026-Q1 | 97.34 | 5.74 | 91.7 | Buyer-sourced | 0 | PASS |
| AX-2025-020180 | CJC-1295 (no DAC) | ERP | ERP-2506-B9718 | VendorInvestigate | 2025-Q4 | 98.83 | 6.00 | 92.9 | Buyer-sourced | 0 | PASS |
| AX-2025-020691 | Sermorelin | SGN | SGN-2502-Y8340 | Janoshik | 2025-Q3 | 98.69 | 5.42 | — | Laboratory-retained | 0 | PASS |
| AX-2025-018705 | TB-500 | QSC | QSC-2504-T6759 | Janoshik | 2025-Q2 | 99.73 | 4.09 | 92.8 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018748 | CJC-1295 (no DAC) | QSC | QSC-2411-D7855 | PeptideMeter | 2025-Q1 | 99.07 | 4.26 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004541 | Hexarelin | HYB | HYB-2407-N7367 | Janoshik | 2024-Q3 | 99.93 | 5.44 | — | Buyer-sourced | 0 | PASS |